Seminars in Thrombosis and Hemostasis

3.8(top 10%)

impact factor

3.7K(top 5%)

papers

109.3K(top 5%)

citations

119(top 5%)

h-index

3.9(top 10%)

impact factor

4.4K

all documents

113.9K

doc citations

172(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Blood Rheology and Hemodynamics	Seminars in Thrombosis and Hemostasis	2003	738
2	A Critical Reappraisal of the Bleeding Time*	Seminars in Thrombosis and Hemostasis	1990	645
3	Fibrinogen as a Hemostatic Agent	Seminars in Thrombosis and Hemostasis	2012	611
4	Hyperhomocysteinemia and Venous Thromboembolism	Seminars in Thrombosis and Hemostasis	2006	567
5	Description of an In Vitro Platelet Function Analyzer-PFA-100™	Seminars in Thrombosis and Hemostasis	1995	459
6	PFA-100™ System: A New Method for Assessment of Platelet Dysfunction	Seminars in Thrombosis and Hemostasis	1998	415
7	Platelet Dysfunction in Renal Failure	Seminars in Thrombosis and Hemostasis	2004	393
8	Hemostasis during Normal Pregnancy and Puerperium	Seminars in Thrombosis and Hemostasis	2003	384
9	Platelets: Physiology and Biochemistry	Seminars in Thrombosis and Hemostasis	2005	381
10	Heterogeneity of the Tumor Vasculature	Seminars in Thrombosis and Hemostasis	2010	329
11	Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon	Seminars in Thrombosis and Hemostasis	1999	325
12	Hemostasis Changes During Cardiopulmonary Bypass Surgery	Seminars in Thrombosis and Hemostasis	1985	308
13	Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis	Seminars in Thrombosis and Hemostasis	1995	302
14	Clopidogrel and Ticlopidine: P2Y12Adenosine Diphosphate-Receptor Antagonists for the Prevention of Atherothrombosis	Seminars in Thrombosis and Hemostasis	2005	302
15	Pathways and Regulation of Homocysteine Metabolism in Mammals	Seminars in Thrombosis and Hemostasis	2000	288
16	Clinical Utility of the PFA-100	Seminars in Thrombosis and Hemostasis	2008	285
17	Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and Prophylaxis	Seminars in Thrombosis and Hemostasis	1997	284
18	Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock	Seminars in Thrombosis and Hemostasis	1998	282
19	Platelets and Angiogenesis in Malignancy	Seminars in Thrombosis and Hemostasis	2004	282
20	Microparticles in Cancer	Seminars in Thrombosis and Hemostasis	2010	267
21	Preclinical and Clinical Studies with Selective Reversible Direct P2Y12Antagonists	Seminars in Thrombosis and Hemostasis	2005	249
22	Pharmacology of CS-747 (prasugrel, LY640315), a Novel, Potent Antiplatelet Agent with in Vivo P2Y12Receptor Antagonist Activity	Seminars in Thrombosis and Hemostasis	2005	241
23	Large Platelets Circulate in an Activated State in Diabetes Mellitus	Seminars in Thrombosis and Hemostasis	1991	240
24	An Overview of the Structure and Function of Thrombin	Seminars in Thrombosis and Hemostasis	2006	233
25	Platelet Physiology	Seminars in Thrombosis and Hemostasis	2016	233
26	Pathophysiology of the Thrombophilic State in the Cancer Patient	Seminars in Thrombosis and Hemostasis	1999	231
27	Inflammation and the Activated Protein C Anticoagulant Pathway	Seminars in Thrombosis and Hemostasis	2006	221
28	Congenital Fibrinogen Disorders: An Update	Seminars in Thrombosis and Hemostasis	2013	218
29	Regulation of Thrombin Generation and Functions	Seminars in Thrombosis and Hemostasis	1988	217
30	Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer	Seminars in Thrombosis and Hemostasis	1991	211
31	COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies	Seminars in Thrombosis and Hemostasis	2020	211
32	Coagulation Abnormalities in Malignancy: A Review	Seminars in Thrombosis and Hemostasis	1992	208
33	Epidemiology of Factor V Leiden: Clinical Implications	Seminars in Thrombosis and Hemostasis	1998	207
34	Neonatal Purpura Fulminans Due to Homozygous Protein C or Protein S Deficiencies	Seminars in Thrombosis and Hemostasis	1990	205
35	Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic Mechanisms	Seminars in Thrombosis and Hemostasis	2008	205
36	Tissue Plasminogen Activator: Chemical and Physiological Aspects	Seminars in Thrombosis and Hemostasis	1984	204
37	Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits	Seminars in Thrombosis and Hemostasis	1985	202
38	Thrombocytopenia and Disorders of Platelet Function in Pregnancy	Seminars in Thrombosis and Hemostasis	2011	202
39	Sources of Tissue Factor	Seminars in Thrombosis and Hemostasis	2006	200
40	Hyperviscosity Syndrome in Plasma Cell Dyscrasias	Seminars in Thrombosis and Hemostasis	2003	199
41	Factor XIII Deficiency	Seminars in Thrombosis and Hemostasis	2009	197
42	The Fc Receptor for Immunoglobulin G (FcγRII) on Human Platelets	Seminars in Thrombosis and Hemostasis	1995	196
43	Factor VII Deficiency	Seminars in Thrombosis and Hemostasis	2009	196
44	NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis	Seminars in Thrombosis and Hemostasis	2014	196
45	A Cell-Based Model of Thrombin Generation	Seminars in Thrombosis and Hemostasis	2006	195
46	Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the Literature	Seminars in Thrombosis and Hemostasis	2012	195
47	Thrombosis in Myeloproliferative Disorders: Prevalence, Prognostic Factors, and the Role of Leukocytes and JAK2V617F	Seminars in Thrombosis and Hemostasis	2007	189
48	Overcoming Limitations of Microparticle Measurement by Flow Cytometry	Seminars in Thrombosis and Hemostasis	2010	189
49	Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation	Seminars in Thrombosis and Hemostasis	2018	189
50	MYH9-Related Platelet Disorders	Seminars in Thrombosis and Hemostasis	2009	187

Scientometrics

Overviews

Citing Bodies

Seminars in Thrombosis and Hemostasis

Top Articles